Oncotelic Therapeutics Inc
(OTLC)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2019 | 03-2019 | 12-2018 | 09-2018 | 06-2018 | |
| Operating Expenses | 1,161 | 976 | -450 | 214 | 153 |
| Operating Income | -1,161 | -976 | 450 | -214 | -153 |
| Interest Expense | 28 | 0 | 0 | 0 | 0 |
| Other Income | 0 | 0 | -1 | 0 | 0 |
| Pre-tax Income | -1,189 | -976 | 449 | -214 | -153 |
| Net Income Continuous | -1,189 | -976 | 449 | -214 | -153 |
| Net Income | $-1,189 | $-976 | $449 | $-214 | $-153 |
| EPS Basic Total Ops | -0.02 | -0.14 | -0.02 | -0.04 | -0.03 |
| EPS Basic Continuous Ops | -0.02 | -0.14 | -0.03 | -0.04 | -0.03 |
| EPS Diluted Total Ops | -0.02 | -0.14 | -0.02 | -0.04 | -0.03 |
| EPS Diluted Continuous Ops | -0.02 | -0.14 | -0.03 | -0.04 | -0.03 |
| EBITDA(a) | $-1,120 | $-963 | $462 | $-201 | $-147 |